Incompatibility of busulfan with 1 ml Luer-Lock syringes
To the Editor, Busulfan followed by cyclophosphamide (BuCy4) or melphalan (BuMel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients. The recommended dose and schedule of administration is 0.8 mg/ kg body weight (BW) of busulfan as a two-hour infusion every 6 h over four consecutive days for a total of 16 doses.
For this preparation, we usually use a 3 ml Luer-Lock syringe (Soft Ject Õ ) to withdraw the busulfan. This solution is mixed with 0.9% sodium chloride by using the Rapid Fill Õ system (Becton Dickinson) in a 60 ml syringe (Penta Õ , Pentaferte) to achieve a 0.5 mg/ mL concentration.
In our hospital, a 3.5 mg dose was prescribed for a 10-month-old child and prepared for administration with an electric syringe. The mixture was performed by using a 1 ml Luer-Lock syringe (Becton Dickinson) to withdraw 0.58 ml of busulfan, because they were more precise than the 3 ml syringes. This volume was mixed with 6.42 ml of 0.9% sodium chloride via the Rapid Fill Õ system as previously described. After mixing the two solutions, we observed an immediate precipitate (Figure 1) . A new syringe was prepared with the same result. No precipitation was observed when replacing the 1 ml Luer-Lock syringe by a 1 ml non-Luer-Lock syringe (BD Plastipak TM , Becton Dickinson) or a 3 ml Luer-Lock syringe (Soft Ject Õ ).
The summary of product characteristics of Busilvex Õ indicates that polycarbonate must not be used with the busulfan solution because it contains dimethylacetamide. This excipient is very aggressive to plastics and has recently been involved in an incompatibility with a needle-free valve. 1 The crystal clear barrel of the 1 ml Luer-Lock BD syringe is made of polycarbonate. 2 However, this information is not written on the package insert of the syringes, and is only available on the internet website of Becton Dickinson.
Standard operating procedures in centralized units must clearly state the materials to be used and this must be respected considering a small change in the preparation can dramatically change in the final quality of the preparation.
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